Patents by Inventor Joe C. Wu

Joe C. Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Membrane derived caspase-3, compositions comprising the same and methods of use therefor
    Patent number: 6762045
    Abstract: Provided are isolated nucleic acids encoding a novel membrane derived caspase-3 and polypeptides expressed therefrom. In one embodiment, the nucleic acid expression vectors that produce membrane derived caspase-3 polypeptide may be introduced into host cells as a gene delivery vehicle. In other embodiments, methods are provided for treating pathological disorders caused by altered apoptosis, such as autoimmune disease, cancer, viral infections, and bacterial infections. Another aspect of the invention is the use of the isolated nucleic acid encoding membrane derived caspase-3 and polypeptides expressed therefrom as a means for promoting or inhibiting programmed cell death.
    Type: Grant
    Filed: March 20, 2002
    Date of Patent: July 13, 2004
    Assignee: Idun Pharmaceuticals, Inc.
    Inventors: Joseph F. Krebs, Anupama Srinivasan, Lawrence C. Fritz, Joe C. Wu
  • Membrane derived caspase-3, compositions comprising the same and methods of use therefor
    Publication number: 20020197702
    Abstract: Provided are isolated nucleic acids encoding a novel membrane derived caspase-3 and polypeptides expressed therefrom. In one embodiment, the nucleic acid expression vectors that produce membrane derived caspase-3 polypeptide may be introduced into host cells as a gene delivery vehicle. In other embodiments, methods are provided for treating pathological disorders caused by altered apoptosis, such as autoimmune disease, cancer, viral infections, and bacterial infections. Another aspect of the invention is the use of the isolated nucleic acid encoding membrane derived caspase-3 and polypeptides expressed therefrom as a means for promoting or inhibiting programmed cell death.
    Type: Application
    Filed: March 26, 2002
    Publication date: December 26, 2002
    Applicant: IDUN Pharmaceuticals, Inc.
    Inventors: Joseph F. Krebs, Anupama Srinivasan, Lawrence C. Fritz, Joe C. Wu
  • Membrane derived caspase-3, compositions comprising the same and methods of use therefor
    Publication number: 20020155579
    Abstract: Provided are isolated nucleic acids encoding a novel membrane derived caspase-3 and polypeptides expressed therefrom. In one embodiment, the nucleic acid expression vectors that produce membrane derived caspase-3 polypeptide may be introduced into host cells as a gene delivery vehicle. In other embodiments, methods are provided for treating pathological disorders caused by altered apoptosis, such as autoimmune disease, cancer, viral infections, and bacterial infections. Another aspect of the invention is the use of the isolated nucleic acid encoding membrane derived caspase-3 and polypeptides expressed therefrom as a means for promoting or inhibiting programmed cell death.
    Type: Application
    Filed: March 20, 2002
    Publication date: October 24, 2002
    Applicant: IDUN Pharmaceuticals, Inc.
    Inventors: Joseph F. Krebs, Anupama Srinivasan, Lawrence C. Fritz, Joe C. Wu